Results 21 to 30 of about 871 (107)

Population Pharmacokinetic Model and Dosing Simulation of Meropenem Using Measured Creatinine Clearance for Patients with Sepsis. [PDF]

Ther Drug Monit, 2023
Fukumoto S, Ohbayashi M, Okada A, Kohyama N, Tamatsukuri T, Inoue H, Kato A, Kotani T, Sagara H, Dohi K, Kogo M.   +10 more
europepmc   +1 more source

Meropenem-induced thrombocytopenia: a paediatric case. [PDF]

BMJ Case Rep, 2021
Cachia J, Torpiano P, Pace D.
europepmc   +1 more source

Quinazolinone-based hybrids with diverse biological activities: A mini-review. [PDF]

J Res Med Sci, 2022
Rezaeinasab R, Jafari E, Khodarahmi G.
europepmc   +1 more source

Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue. [PDF]

Antimicrob Agents Chemother, 2022
Alshaer MH, Barlow B, Maranchick N, Moser M, Gramss L, Burgmann H, Jalali VA, Wölfl-Duchek M, Jäger W, Poschner S, Plöchl W, Reinprecht A, Rössler K, Gruber A, Zeitlinger M, Peloquin CA, Hosmann A.   +16 more
europepmc   +1 more source

A case of carbapenamase production in <i>Shigella flexneri</i> isolated in Ireland, 2025. [PDF]

Euro Surveill
Clarke C, Tuohy A, Duignan E, Mullane P, Carolan AM, Craig O, Miliotis G, Dillon C, Cormican M.   +8 more
europepmc   +1 more source

A rare complication following excision and primary anastomosis urethroplasty: Osteomyelitis: a case report. [PDF]

Medicine (Baltimore)
Uğur R, Şevik Ç, Şevik BÖ, Canat HL.   +3 more
europepmc   +1 more source

Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections. [PDF]

Antimicrob Agents Chemother
Karaba SM, Hareza DA, Munita JM, Martinez JRW, Bergman Y, Hawes AM, Bulman ZP, Cosgrove SE, Simner PJ, Tamma PD.   +9 more
europepmc   +1 more source

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis. [PDF]

Microbiol Spectr, 2023
Pahuja I, Verma A, Ghoshal A, Mukhopadhyay S, Kumari A, Shaji A, Chaturvedi S, Dwivedi VP, Bhaskar A.   +8 more
europepmc   +1 more source

Meropenem: continuous or extended infusion? [PDF]

Crit Care, 2020
Frippiat F, Vercheval C, Layios N.
europepmc   +1 more source

Low levels of the second messenger c-di-GMP enhance tolerance and resistance to meropenem in <i>Pseudomonas aeruginosa</i>. [PDF]

Front Cell Infect Microbiol
Brignoli T, Ferrara S, Labrini E, Bertoni G.   +3 more
europepmc   +1 more source